Skip to main content
. 2021 Jun 15;112(8):3255–3265. doi: 10.1111/cas.14980

FIGURE 4.

FIGURE 4

Kaplan‐Meier analysis of progression‐free survival‐2 (PFS2) in the intent‐to‐treat population. PFS2 was defined as the time from randomization to objective tumor progression on next‐line treatment (including subsequent anti–PD‐[L]1 therapy) or death from any cause, whichever occurred first.19 HR, hazard ratio; NR, not reached; PD‐(L)1, programmed death 1 or programmed death ligand 1